BlackRock, Inc. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
6,351,750 10.700% |
86,745 (+1.38%) |
Filing |
| 2023-07-07 4:35 pm Purchase |
2023-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
6,265,005 11.000% |
2,541,291 (+68.25%) |
Filing |
| 2023-02-03 12:09 pm Purchase |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
3,723,714 6.600% |
2,546,139 (+216.22%) |
Filing |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
1,177,575 2.300% |
-2,150,486 (-64.62%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
3,328,061 6.600% |
596,955 (+21.86%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
BlackRock Inc. BLK |
2,731,106 6.200% |
176,340 (+6.90%) |
Filing |